Live Oak Private Wealth LLC Has $6.06 Million Stake in Agilent Technologies, Inc. (NYSE:A)

Live Oak Private Wealth LLC boosted its position in Agilent Technologies, Inc. (NYSE:A) by 0.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 45,129 shares of the medical research company’s stock after purchasing an additional 82 shares during the period. Live Oak Private Wealth LLC’s holdings in Agilent Technologies were worth $6,063,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Massachusetts Financial Services Co. MA raised its position in Agilent Technologies by 3.5% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 15,589,874 shares of the medical research company’s stock worth $2,314,784,000 after purchasing an additional 525,214 shares during the last quarter. State Street Corp increased its stake in shares of Agilent Technologies by 1.2% in the third quarter. State Street Corp now owns 12,819,897 shares of the medical research company’s stock valued at $1,903,498,000 after buying an additional 158,175 shares during the period. Geode Capital Management LLC raised its position in shares of Agilent Technologies by 0.4% during the third quarter. Geode Capital Management LLC now owns 6,948,679 shares of the medical research company’s stock worth $1,028,241,000 after acquiring an additional 30,610 shares during the last quarter. Nordea Investment Management AB lifted its stake in shares of Agilent Technologies by 2.6% in the fourth quarter. Nordea Investment Management AB now owns 3,198,715 shares of the medical research company’s stock worth $431,603,000 after acquiring an additional 80,819 shares during the period. Finally, Van ECK Associates Corp boosted its holdings in Agilent Technologies by 6.6% in the third quarter. Van ECK Associates Corp now owns 2,976,905 shares of the medical research company’s stock valued at $442,011,000 after acquiring an additional 183,716 shares during the last quarter.

Insider Activity

In related news, CEO Padraig Mcdonnell sold 1,911 shares of the business’s stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total value of $286,650.00. Following the transaction, the chief executive officer now directly owns 39,652 shares of the company’s stock, valued at approximately $5,947,800. The trade was a 4.60 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Analysts Set New Price Targets

Several research analysts have issued reports on A shares. StockNews.com upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Tuesday, December 24th. Sanford C. Bernstein dropped their target price on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating on the stock in a report on Tuesday, November 26th. JPMorgan Chase & Co. decreased their price target on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a report on Tuesday, November 26th. Bank of America dropped their price objective on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a research note on Friday, December 13th. Finally, Citigroup raised their target price on Agilent Technologies to $165.00 and gave the stock a “buy” rating in a research note on Thursday, December 19th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $143.62.

Agilent Technologies Trading Down 0.2 %

A opened at $147.66 on Friday. The firm has a market capitalization of $42.17 billion, a PE ratio of 33.41, a P/E/G ratio of 4.10 and a beta of 1.07. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.09 and a quick ratio of 1.58. Agilent Technologies, Inc. has a fifty-two week low of $124.16 and a fifty-two week high of $155.35. The company’s 50-day moving average is $141.25 and its 200 day moving average is $139.13.

Agilent Technologies (NYSE:A) last posted its earnings results on Monday, November 25th. The medical research company reported $1.46 earnings per share for the quarter, beating analysts’ consensus estimates of $1.41 by $0.05. Agilent Technologies had a return on equity of 25.43% and a net margin of 19.80%. The company had revenue of $1.70 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same quarter last year, the company earned $1.38 earnings per share. The company’s revenue for the quarter was up .8% on a year-over-year basis. As a group, research analysts predict that Agilent Technologies, Inc. will post 5.56 earnings per share for the current fiscal year.

Agilent Technologies Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, January 22nd. Stockholders of record on Tuesday, December 31st were issued a $0.248 dividend. The ex-dividend date of this dividend was Tuesday, December 31st. This represents a $0.99 annualized dividend and a dividend yield of 0.67%. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.24. Agilent Technologies’s dividend payout ratio is currently 22.40%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.